What is OS Therapies's interest income?

OS Therapies (OSTX) reported interest income of $45 in Q1 2026.

How has OS Therapies's interest income changed year-over-year?

OS Therapies's interest income decreased by 31.8% year-over-year, from $66 to $45.

What does interest income mean?

Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

OS Therapies OSTX Interest Income

Interest Income at other companies

CTO

Citius Oncology, Inc.CTOR

$43.72K+381%

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

$1.33M+67.9%

Segments

By segment

See full

Chief Operating Decision Maker$45-31.8%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's interest income?: OS Therapies (OSTX) reported interest income of $45 in Q1 2026.
How has OS Therapies's interest income changed year-over-year?: OS Therapies's interest income decreased by 31.8% year-over-year, from $66 to $45.
What does interest income mean?: Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.